Photoactivatable opiate derivatives as irreversible probes of the .mu.-opioid receptor

Journal of Medicinal Chemistry
1990.0

Abstract

The synthesis of aryldiazonium and arylazido derivatives of carfentanil, etonitazene, and naltrexone and of a triazaspirodecane derivative is described. The chemical stability and the spectral characteristics of these compounds were verified, and their binding affinity constants for the different opioid receptor classes were determined, in the absence of light, from competition experiments. With the exception of the naltrexyl derivatives, which remained nonselective, all compounds tested displayed a pronounced mu-binding selectivity with mu/delta and mu/kappa ratios ranging from 12 to 1000. After irradiation, only the arylazido probes led to an irreversible mu-binding-site inactivation. This inactivation fulfilled the criteria for photoaffinity labeling such as protection against inactivation by other opiate ligands and absence of an effect of scavengers on the extent of the inactivation. Most of the photoactivatable probes formed long-lasting reversible complexes with the opioid binding sites: an efficient dissociation procedure was thus required to discriminate between pseudoirreversible and covalent complexes. The marked differences in labeling efficacy between aryldiazonium salts and their corresponding arylazido derivatives are discussed.

Knowledge Graph

Similar Paper

Photoactivatable opiate derivatives as irreversible probes of the .mu.-opioid receptor
Journal of Medicinal Chemistry 1990.0
Potential affinity labels for the opiate receptor based on fentanyl and related compounds
Journal of Medicinal Chemistry 1982.0
A photoaffinity reagent to label the opiate receptors of guinea pig ileum and mouse vas deferens
Journal of Medicinal Chemistry 1984.0
Synthesis of Substituted 3-Carbamoylecgonine Methyl Ester Analogs: Irreversible and Photoaffinity Ligands for the Cocaine Receptor/Dopamine Transporter
Journal of Medicinal Chemistry 1994.0
Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different .mu. receptor subtypes in different tissues
Journal of Medicinal Chemistry 1984.0
Aryl diazo compounds and diazonium salts as potential irreversible probes of the GABA receptor
Journal of Medicinal Chemistry 1987.0
Synthesis, Biological Evaluation, and Utility of Fluorescent Ligands Targeting the μ-Opioid Receptor
Journal of Medicinal Chemistry 2015.0
Electrophilic opioid ligands. Oxygen-tethered .alpha.-methylene-.gamma.-lactone, acrylate, isothiocyanate, and epoxide derivatives of 6.beta.-naltrexol
Journal of Medicinal Chemistry 1992.0
Generation of novel radiolabeled opiates through site-selective iodination
Bioorganic & Medicinal Chemistry Letters 2011.0
Importance of carbon 6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labels
Journal of Medicinal Chemistry 1983.0